@BakedBlossoms
Wait until 2022 and see if you still feel duped. This is just the beginning.
Hardly, a successful vaccine has already pretty much been found.
This is the problem with having medical trials being commentated on as they're happening by journalists who lack the experience to know what they're talking about.
A vaccine has not 'pretty much been found'. What's been demonstrated is that a number of vaccines elicit immune responses in the form of antibodies and T-cells.
Some of those antibodies are neutralising, meaning they're on target for this virus. Others are not neutralising - they're antibodies that are off target. Why does this matter? Off target antibodies may cause something called antibody dependent enhancement. It was a feature of the SARS vaccines that were in development. Off target antibodies actually make infection worse.
www.nature.com/articles/s41587-020-0577-1
www.frontiersin.org/articles/10.3389/fimmu.2020.01120/full
These vaccines may actually make infection worse. The only way we'll know whether they do is when a significant number of vaccinated people have been exposed to the virus, which is why large scale studies are underway in Brazil, India and elsewhere.
Even if the vaccines work as intended, they will be the first successful vaccines against human coronaviruses. Our natural immunity to coronavirus infection is temporary, lasting between 30 days and 3 years, depending on the variety of coronavirus and the individual's immune system. There is no reason to expect the vaccines will give us anything other than temporary protection, which is a problem for the Oxford virus in particular. It uses a genetically engineered chimpanzee adenovirus as the wrapper to deliver the SARS-CoV-2 spike. Humans will become immune to the wrapper, making the delivery mechanism ineffective. The Oxford technology was designed for diseases we can elicit long-term immunity to: TB, influenza etc. It may run into trouble if it needs to be boosted on a regular basis.
Based on the Oxford vaccine data, which is showing that 10% of people who participated did not produce any antibodies whatsoever, I believe the vaccines will encounter exactly the same issues as people who've been infected with live virus. Immunity will be short-lived, some people will not develop any immunity at all, and reinfection will be a persistent problem.
It's also worth pointing out that some scientists believe we're already seeing antibody dependent enhancement through cross infection of the different strains of the virus, which is why some countries are experiencing higher mortality rates than others.
www.medrxiv.org/content/10.1101/2020.07.13.20152959v1
So, no, a vaccine has not been pretty much found, and even if it has, it will be of limited use and take a few years to distribute to the global population. Remain cautious and plan your life on the basis the virus will be with us until at least the end of summer 2021.